Quick Guide

A bacterial STD panel screens for four common, curable sexually transmitted infections using a blood sample and a urine sample. It covers chlamydia, gonorrhea, syphilis, and trichomoniasis. No fasting, no swabs, no physical exam.

If you recently had unprotected sex or a possible exposure to any of these four infections, consider testing soon. Each infection has a different window period, the time between exposure and when the test can detect it. Nucleic acid amplification test (NAAT) picks up chlamydia and gonorrhea roughly one to two weeks after exposure. Syphilis RPR (rapid plasma reagin) may not become reactive until three to six weeks out. Trichomoniasis has an incubation period of five to 28 days after exposure; the NAAT detection window generally aligns with this range, though the CDC does not publish a specific exposure-to-detection window for trichomoniasis NAAT. A negative result early in the window doesn’t rule out infection. Retest after the window closes if you had a confirmed exposure or symptoms show up.

About the Bacterial Infection STD Panel

Purpose of the test

This panel screens for or confirms four curable sexually transmitted infections (STIs) in a single visit. (Many) people with chlamydia, gonorrhea, and trichomoniasis don’t have symptoms, so testing is the only reliable way to know your status. Syphilis can go unnoticed in early stages too, but it moves through stages and can cause serious organ damage if it isn’t treated.

Catching these infections early matters. Untreated chlamydia and gonorrhea can lead to pelvic inflammatory disease (PID), infertility, and pregnancy complications. Syphilis can damage the brain, heart, and nerves in later stages. Trichomoniasis has been linked to premature birth and low birth weight, according to the CDC’s trichomoniasis fact sheet.

One thing worth clarifying: trichomoniasis is caused by a parasite (Trichomonas vaginalis), not a bacterium. It’s included here because it’s curable with the same class of antibiotics used for bacterial STIs and is routinely co-tested with chlamydia, gonorrhea, and syphilis. The “bacterial” label refers to the panel’s focus on curable, antibiotic-treatable infections.

This panel does NOT screen for HIV, herpes (HSV-1 or HSV-2), hepatitis B, hepatitis C, HPV, or other STIs.

  • Screening: The CDC’s STI screening recommendations call for routine screening for sexually active adults at higher risk, including women under 25 and men who have sex with men (MSM). High Risk means more than one sex partner or a sex partner with a known STI. Inconsistent condom use when not in a mutually monogamous relationship. Exchanging sex for money or Injection drug use.
  • Diagnosis: Ordered when symptoms like unusual discharge, painful urination, or genital sores are present.
  • Monitoring: Not a monitoring test; used for initial detection before treatment.

What does the Bacterial Infection STD Panel measure?

The panel uses two detection approaches depending on the pathogen.

  • NAAT for chlamydia and gonorrhea: Detects bacterial DNA in your urine sample. NAAT is the most accurate method for these two infections and is the standard at CLIA-certified labs. It won’t detect throat or rectal infections from urine; a swab at a clinic is needed for those sites.
  • NAAT for trichomoniasis: Detects Trichomonas vaginalis DNA in the same urine sample. More sensitive than older microscopy methods.
  • RPR for syphilis: A blood-based screening test that detects antibodies your body makes in response to syphilis. If the RPR is reactive, the lab automatically runs a confirmatory treponemal antibody test on the same sample at no extra cost.
  • Treponemal confirmatory test for syphilis: Run automatically when RPR is reactive. Confirms syphilis before treatment begins.

NAAT finds a pathogen’s genetic material directly. That makes it more accurate than older culture-based methods.

When should I get a Bacterial Infection STD Panel?

Consider testing if any of these apply:

  • Symptoms like unusual discharge, burning urination, or genital sores
  • A possible exposure to any of these four infections
  • A sexual partner recently diagnosed with chlamydia, gonorrhea, syphilis, or trichomoniasis
  • A new sex partner or multiple sex partners
  • Inconsistent condom use
  • A prior STI diagnosis
  • A current pregnancy

For routine screening, the CDC’s STI screening recommendations advise:

  • All sexually active women under 25: annual screening for chlamydia and gonorrhea
  • Women 25 and older with risk factors (new partner, multiple partners, partner with an STI, inconsistent condom use): annual screening for chlamydia and gonorrhea
  • Gay, bisexual, and other men who have sex with men (MSM): at least annual screening for syphilis, chlamydia, and gonorrhea at all exposed sites; every three to six months if at higher risk
  • Pregnant women: at the first prenatal visit for chlamydia, gonorrhea, and syphilis; rescreen for chlamydia and gonorrhea in the third trimester if under 25 or at higher risk; rescreen for syphilis at 28 weeks and at delivery if at increased risk
  • Anyone diagnosed with HIV: at the first HIV evaluation and at least annually after

The U.S. Preventive Services Task Force also issues independent screening recommendations for chlamydia, gonorrhea, and syphilis that align with these guidelines and may be relevant if your provider follows USPSTF guidance.

How It Works

How to get tested

This panel is available through CLIA-certified labs including LabCorp and Quest Diagnostics. Visit a nearby patient service center for your blood draw and urine sample. Results arrive in your secure online account.

This test is also available through a provider’s office or clinic.

Prefer to test privately from home? Chlamydia, gonorrhea, syphilis, and trichomoniasis are included in at-home STD tests. The kit ships to your door with instructions, collection materials, and prepaid return shipping.

Before the test

No fasting required. Eat and drink normally.

The most important prep step: don’t urinate for at least one hour before you provide your urine sample. Urinating too close to your appointment can dilute the sample and throw off NAAT accuracy for chlamydia, gonorrhea, and trichomoniasis.

If you’re taking a biotin supplement (also called vitamin B7, found in many hair, nail, and skin products), wait at least 72 hours after your last dose before the blood draw. Biotin can interfere with certain blood tests, including some syphilis assays.

Tell the lab technician if you’re currently taking antibiotics. Active antibiotic use can affect results.

During the test

The lab visit involves two separate samples. The blood draw comes first.

A technician draws a small blood sample from a vein in your arm. You’ll feel a brief pinch. A small bandage covers the site when it’s done. Mild bruising or soreness is normal and clears up within a day or two.

Next, you’ll provide a urine sample in a collection cup. This is first-catch urine, meaning the first portion of your stream. The lab uses this sample for chlamydia, gonorrhea, and trichomoniasis NAAT. It’s painless.

No swabs. No physical exam. The whole visit takes about 15 to 20 minutes.

Call your provider if you notice lasting pain, swelling, or signs of infection at the draw site after you leave.

After the test

Results are ready within one to three business days after the lab receives your samples. You’ll get an email when they’re available in your secure online account. If your test was ordered through a provider’s office, timing may vary.

What do my results mean?

Your report shows a separate result for each of the four infections. Syphilis results include two parts: the RPR screening result and, if the RPR is reactive, an automatic confirmatory treponemal test run on the same sample.

If your results are negative

No infection was found. That’s reassuring, but timing matters.

Each infection has a different detection window. If you tested soon after a possible exposure, keep these timelines in mind:

  • Chlamydia and gonorrhea: detectable about one to two weeks after exposure via NAAT
  • Syphilis: RPR may not be reactive until three to six weeks after exposure
  • Trichomoniasis: incubation period is five to 28 days after exposure; the NAAT detection window generally aligns with this range

A negative result early in the window doesn’t rule out infection. Retest after the window closes if your exposure was confirmed or symptoms show up.

A negative result here doesn’t cover HIV, herpes, hepatitis B, hepatitis C, or other STIs not in this panel.

If your results are positive

One or more infections were found. Don’t panic. All four are curable with antibiotics, and treatment works well when you start promptly.

Here’s what to know for each infection:

Chlamydia and trichomoniasis: Both respond well to antibiotics. Avoid sexual activity until treatment is complete and your provider confirms the infection has cleared.

Gonorrhea: Treatable, but guidelines have changed due to antibiotic resistance. The CDC’s gonorrhea treatment guidelines recommend a single 500 mg intramuscular dose of ceftriaxone as first-line treatment. Don’t self-treat or use leftover antibiotics. Your provider will pick the right regimen.

Syphilis: If your RPR is reactive, the lab runs a confirmatory treponemal test on the same sample automatically. A positive confirmatory result may indicate syphilis is confirmed. Penicillin treatment is highly effective, especially in early stages.

Notify recent sexual partners so they can get tested and treated. Reinfection is common if both partners aren’t treated at the same time. Follow up with your provider to discuss treatment, any STI screening (HIV, hepatitis, herpes) not covered by this panel, and a retest timeline.

FAQs

Does this panel test for HIV or herpes?

No. It screens for chlamydia, gonorrhea, syphilis, and trichomoniasis only. It doesn’t include HIV, herpes (HSV-1 or HSV-2), hepatitis B, hepatitis C, or HPV. If you want broader coverage, consider a comprehensive STD panel.

Can I pass any of these infections to my baby during pregnancy?

Yes. All four infections can cause complications during pregnancy or delivery. Syphilis can cause miscarriage, stillbirth, or congenital syphilis in the newborn. Chlamydia and gonorrhea can cause eye infections or pneumonia in newborns. Trichomoniasis has been linked to premature birth and low birth weight. Testing early in pregnancy and treating any positive results protects both you and your baby.

When should I retest after treatment?

The CDC’s treatment guidelines recommend retesting for chlamydia and gonorrhea approximately three months after finishing treatment, even if you and your partner were both treated. Reinfection is common. For syphilis, your provider will schedule follow-up blood tests at set intervals to confirm the infection has cleared.

Why is trichomoniasis included in a bacterial STD panel if it's caused by a parasite?

Trichomoniasis is caused by a parasite (Trichomonas vaginalis), not a bacterium. It’s included because it’s curable with the same class of antibiotics used for bacterial STIs and is routinely co-tested with chlamydia, gonorrhea, and syphilis. The “bacterial” label refers to the panel’s focus on curable, antibiotic-treatable infections.

What's the difference between this panel and a comprehensive STD panel?

This panel covers four curable infections: chlamydia, gonorrhea, syphilis, and trichomoniasis. A comprehensive STD panel adds viral infections like HIV, hepatitis B, hepatitis C, and sometimes herpes. Choose this panel for targeted post-exposure screening. Choose a comprehensive panel if you want HIV and hepatitis coverage in the same visit.

Sources

See More